Oligodendrocyte Physiology and Pathology Function
Introduction
References
- Armati, P.; Mathey, E. The Biology of Oligodendrocytes; Cambridge University Press: Cambridge, UK, 2010. [Google Scholar]
- Jäkel, S.; Dimou, L. Glial cells and their function in the adult brain: A journey through the history of their ablation. Front. Cell. Neurosci. 2017, 11, 24. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bradl, M.; Lassmann, H. Oligodendrocytes: Biology and pathology. Acta Neuropathol. 2010, 119, 37–53. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Caprariello, A.V.; Mangla, S.; Miller, R.H.; Selkirk, S.M. Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination. Ann. Neurol. 2012, 72, 395–405. [Google Scholar] [CrossRef] [PubMed]
- Traka, M.; Podojil, J.R.; McCarthy, D.P.; Miller, S.D.; Popko, B. Oligodendrocyte death results in immune-mediated CNS demyelination. Nat. Neurosci. 2016, 19, 65–74. [Google Scholar] [CrossRef]
- Popescu, B.F.G.; Pirko, I.; Lucchinetti, C.F. Pathology of multiple sclerosis: Where do we stand? CONTIN. Lifelong Learn. Neurol. 2013, 19, 901. [Google Scholar] [CrossRef]
- DeLuca, G.; Williams, K.; Evangelou, N.; Ebers, G.; Esiri, M. The contribution of demyelination to axonal loss in multiple sclerosis. Brain 2006, 129, 1507–1516. [Google Scholar] [CrossRef]
- Funfschilling, U.; Supplie, L.M.; Mahad, D.; Boretius, S.; Saab, A.S.; Edgar, J.; Brinkmann, B.G.; Kassmann, C.M.; Tzvetanova, I.D.; Mobius, W.; et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 2012, 485, 517–521. [Google Scholar] [CrossRef] [Green Version]
- Edgar, J.M.; McLaughlin, M.; Yool, D.; Zhang, S.C.; Fowler, J.H.; Montague, P.; Barrie, J.A.; McCulloch, M.C.; Duncan, I.D.; Garbern, J.; et al. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J. Cell Biol. 2004, 166, 121–131. [Google Scholar] [CrossRef]
- Uschkureit, T.; Sporkel, O.; Stracke, J.; Bussow, H.; Stoffel, W. Early onset of axonal degeneration in double (plp-/-mag-/-) and hypomyelinosis in triple (plp-/-mbp-/-mag-/-) mutant mice. J. Neurosci. 2000, 20, 5225–5233. [Google Scholar] [CrossRef] [Green Version]
- Enz, L.S.; Zeis, T.; Hauck, A.; Linington, C.; Schaeren-Wiemers, N. Combinatory Multifactor Treatment Effects on Primary Nanofiber Oligodendrocyte Cultures. Cells 2019, 8, 1422. [Google Scholar] [CrossRef] [Green Version]
- Zhan, J.; Yakimov, V.; Rühling, S.; Fischbach, F.; Nikolova, E.; Joost, S.; Kaddatz, H.; Greiner, T.; Frenz, J.; Holzmann, C.; et al. High Speed Ventral Plane Videography as a Convenient Tool to Quantify Motor Deficits during Pre-Clinical Experimental Autoimmune Encephalomyelitis. Cells 2019, 8, 1439. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Joost, S.; Mikkat, S.; Wille, M.; Schümann, A.; Schmitt, O. Membrane Protein Identification in Rodent Brain Tissue Samples and Acute Brain Slices. Cells 2019, 8, 423. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hochstrasser, T.; Rühling, S.; Hecher, K.; Fabisch, K.H.; Chrzanowski, U.; Brendel, M.; Eckenweber, F.; Sacher, C.; Schmitz, C.; Kipp, M. Stereological Investigation of Regional Brain Volumes after Acute and Chronic Cuprizone-Induced Demyelination. Cells 2019, 8, 1024. [Google Scholar] [CrossRef] [Green Version]
- Khodanovich, M.; Pishchelko, A.; Glazacheva, V.; Pan, E.; Akulov, A.; Svetlik, M.; Tyumentseva, Y.; Anan’ina, T.; Yarnykh, V. Quantitative Imaging of White and Gray Matter Remyelination in the Cuprizone Demyelination Model Using the Macromolecular Proton Fraction. Cells 2019, 8, 1204. [Google Scholar] [CrossRef] [Green Version]
- Reiche, L.; Küry, P.; Göttle, P. Aberrant Oligodendrogenesis in Down Syndrome: Shift in Gliogenesis? Cells 2019, 8, 1591. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Raabe, F.J.; Slapakova, L.; Rossner, M.J.; Cantuti-Castelvetri, L.; Simons, M.; Falkai, P.G.; Schmitt, A. Oligodendrocytes as A New Therapeutic Target in Schizophrenia: From Histopathological Findings to Neuron-Oligodendrocyte Interaction. Cells 2019, 8, 1496. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nocita, E.; Del Giovane, A.; Tiberi, M.; Boccuni, L.; Fiorelli, D.; Sposato, C.; Romano, E.; Basoli, F.; Trombetta, M.; Rainer, A.; et al. EGFR/ErbB Inhibition Promotes OPC Maturation up to Axon Engagement by Co-Regulating PIP2 and MBP. Cells 2019, 8, 844. [Google Scholar] [CrossRef] [Green Version]
- Yuan, Z.; Chen, P.; Zhang, T.; Shen, B.; Chen, L. Agenesis and Hypomyelination of Corpus Callosum in Mice Lacking Nsun5, an RNA Methyltransferase. Cells 2019, 8, 552. [Google Scholar] [CrossRef] [Green Version]
- Schäfer, I.; Kaisler, J.; Scheller, A.; Kirchhoff, F.; Haghikia, A.; Faissner, A. Conditional Deletion of LRP1 Leads to Progressive Loss of Recombined NG2-Expressing Oligodendrocyte Precursor Cells in a Novel Mouse Model. Cells 2019, 8, 1550. [Google Scholar] [CrossRef] [Green Version]
- Kipp, M.; Amor, S. FTY720 on the way from the base camp to the summit of the mountain: Relevance for remyelination. Mult. Scler. J. 2012, 18, 258–263. [Google Scholar] [CrossRef]
- Prineas, J.W.; Connell, F. Remyelination in multiple sclerosis. Ann. Neurol. 1979, 5, 22–31. [Google Scholar] [CrossRef] [PubMed]
- Prineas, J.W.; Barnard, R.O.; Kwon, E.E.; Sharer, L.R.; Cho, E.S. Multiple sclerosis: Remyelination of nascent lesions. Ann. Neurol. 1993, 33, 137–151. [Google Scholar] [CrossRef] [PubMed]
- Gingele, S.; Henkel, F.; Heckers, S.; Moellenkamp, T.M.; Hümmert, M.W.; Skripuletz, T.; Stangel, M.; Gudi, V. Delayed Demyelination and Impaired Remyelination in Aged Mice in the Cuprizone Model. Cells 2020, 9, 945. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nyamoya, S.; Steinle, J.; Chrzanowski, U.; Kaye, J.; Schmitz, C.; Beyer, C.; Kipp, M. Laquinimod Supports Remyelination in Non-Supportive Environments. Cells 2019, 8, 1363. [Google Scholar] [CrossRef] [Green Version]
- Kuhn, S.; Gritti, L.; Crooks, D.; Dombrowski, Y. Oligodendrocytes in Development, Myelin Generation and Beyond. Cells 2019, 8, 1424. [Google Scholar] [CrossRef] [Green Version]
- Tiane, A.; Schepers, M.; Rombaut, B.; Hupperts, R.; Prickaerts, J.; Hellings, N.; van den Hove, D.; Vanmierlo, T. From OPC to Oligodendrocyte: An Epigenetic Journey. Cells 2019, 8, 1236. [Google Scholar] [CrossRef] [Green Version]
- Nutma, E.; van Gent, D.; Amor, S.; Peferoen, L.A.N. Astrocyte and Oligodendrocyte Cross-Talk in the Central Nervous System. Cells 2020, 9, 600. [Google Scholar] [CrossRef] [Green Version]
- Kriszta, G.; Nemes, B.; Sándor, Z.; Ács, P.; Komoly, S.; Berente, Z.; Bölcskei, K.; Pintér, E. Investigation of Cuprizone-Induced Demyelination in mGFAP-Driven Conditional Transient Receptor Potential Ankyrin 1 (TRPA1) Receptor Knockout Mice. Cells 2019, 9, 81. [Google Scholar] [CrossRef] [Green Version]
- Jensen, S.K.; Michaels, N.J.; Ilyntskyy, S.; Keough, M.B.; Kovalchuk, O.; Yong, V.W. Multimodal Enhancement of Remyelination by Exercise with a Pivotal Role for Oligodendroglial PGC1α. Cell Rep. 2018, 24, 3167–3179. [Google Scholar] [CrossRef] [Green Version]
- Tobore, T.O. Oxidative/Nitroxidative Stress and Multiple Sclerosis. J. Mol. Neurosci. 2020, 1–9. [Google Scholar] [CrossRef]
- Serdar, M.; Mordelt, A.; Müser, K.; Kempe, K.; Felderhoff-Müser, U.; Herz, J.; Bendix, I. Detrimental Impact of Energy Drink Compounds on Developing Oligodendrocytes and Neurons. Cells 2019, 8, 1381. [Google Scholar] [CrossRef] [Green Version]
- Nagoshi, N.; Khazaei, M.; Ahlfors, J.E.; Ahuja, C.S.; Nori, S.; Wang, J.; Shibata, S.; Fehlings, M.G. Human Spinal Oligodendrogenic Neural Progenitor Cells Promote Functional Recovery After Spinal Cord Injury by Axonal Remyelination and Tissue Sparing. Stem Cells Transl. Med. 2018, 7, 806–818. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mathys, H.; Davila-Velderrain, J.; Peng, Z.; Gao, F.; Mohammadi, S.; Young, J.Z.; Menon, M.; He, L.; Abdurrob, F.; Jiang, X.; et al. Single-cell transcriptomic analysis of Alzheimer’s disease. Nature 2019, 570, 332–337. [Google Scholar] [CrossRef] [PubMed]
- Kishida, N.; Maki, T.; Takagi, Y.; Yasuda, K.; Kinoshita, H.; Ayaki, T.; Noro, T.; Kinoshita, Y.; Ono, Y.; Kataoka, H.; et al. Role of Perivascular Oligodendrocyte Precursor Cells in Angiogenesis After Brain Ischemia. J. Am. Heart Assoc. 2019, 8, e011824. [Google Scholar] [CrossRef] [Green Version]
- Falcão, A.M.; van Bruggen, D.; Marques, S.; Meijer, M.; Jäkel, S.; Agirre, E.; Samudyata; Floriddia, E.M.; Vanichkina, D.P.; Ffrench-Constant, C.; et al. Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis. Nat. Med. 2018, 24, 1837–1844. [Google Scholar] [CrossRef]
© 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kipp, M. Oligodendrocyte Physiology and Pathology Function. Cells 2020, 9, 2078. https://doi.org/10.3390/cells9092078
Kipp M. Oligodendrocyte Physiology and Pathology Function. Cells. 2020; 9(9):2078. https://doi.org/10.3390/cells9092078
Chicago/Turabian StyleKipp, Markus. 2020. "Oligodendrocyte Physiology and Pathology Function" Cells 9, no. 9: 2078. https://doi.org/10.3390/cells9092078